Skip to content


Volume 16 Supplement 1

1st Joint ANIRCEF-SISC Congress

  • Invited speaker presentation
  • Open Access

Molecular genotype in migraine

  • 1,
  • 2,
  • 3 and
  • 3Email author
The Journal of Headache and Pain201516 (Suppl 1) :A30

  • Published:


  • Migraine
  • Expert Panel
  • Migraine With Aura
  • Headache Disorder
  • Genetic Contribution

Migraine is an episodic brain disorder with disabling attacks of headache that are associated with nausea, vomiting, and hypersensitivity to light, sound, and smell. According to major criteria of the International Classification of Headache Disorders (ICHD-II) from the International Headache Society (IHS), migraine is divided into two main subtypes that are based on the absence (migraine without aura, MO) or presence (migraine with aura, MA) of an aura. Migraine has a profound effect on wellbeing and general functioning, not only during attacks, but also in terms of work performance, family and social relationships, and, mainly in children, school achievement, thus explaining why the WHO expert panel rates migraine among the most disabling and costly chronic disorders.

There is a strong genetic component in migraine as evidenced by observations that the disorder runs in families and that about 50% of the patients have close relatives also affected by a similar condition. However, migraine risk is also conferred by environmental factors and epidemiological evidence suggesting a tight gene-environment interaction (endogenous or exogenous), among which several predisposing or triggering factors have been defined.

In the past decades, our growing understanding of the genetic contributions in migraine disorders has been translated in better knowledge of the pathophysiology but needs to grow further and to be translated into more effective treatments. Indeed, several genes involved in syndromic and monogenic forms of migraine have been defined, allowing a significant contribution to the mechanisms generating the attacks, but the timing and specific contribution of secondary hits remain largely unclear.

Authors’ Affiliations

Don Gnocchi Foundation, Milan, Italy
Laboratory of Neurogenetics, C. Mondino National Institute of Neurology Foundation, IRCCS, Pavia, Italy
Molecular Medicine, IRCCS Stella Maris, Pisa, Italy


© Di Lorenzo et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.